Ronald Harold Wilfred Cooper
CIK 1676880 · CEO & President · last filed 2026-06-26
Ronald Harold Wilfred Cooper is a CEO & President who has filed 39 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for CCCC, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$119.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.6K
5
39
-$119.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCCC | Director | — | $3.55 | — | $0 | 3 | 2026-06-26 |
| Generation Bio Co. (GBIO) Delisted | Director | 0 | $5.34 | $0 | $0 | 7 | 2026-02-09 |
| ENGNW | CEO & President | 10,000 | $0.36 | $3.6K | $57.0K | 4 | 2026-02-03 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | President and CEO | 0 | $44.15 | $0 | -$176.1K | 20 | 2023-03-02 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | — | $0.00 | — | $0 | 5 | 2020-06-19 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | Generation Bio Co. (GBIO) Delisted | Mixed | −950 | $0 | EDGAR |
| 2026-02-03 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-31 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2024-10-01 | ENGNW | Buy (P) | +10,000 | $57.0K | EDGAR |
| 2024-07-24 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.